Novartis to Acquire Regulus Therapeutics in $1.7 Billion Deal, Sending Stock Soaring

As of this writing, Regulus Therapeutics Inc. (RGLS) is one of the top gainers in the…

Novartis is watching US reciprocal tariff policy 'very carefully', CEO says

Novartis is watching US reciprocal tariff policy 'very carefully', CEO says#Novartis #watching #reciprocal #tariff #policy #039very…

Novartis agrees to acquire Anthos for up to $3.1 billion

Novartis agrees to acquire Anthos for up to $3.1 billion#Novartis #agrees #acquire #Anthos #billion

Novartis: Explaining YE24 Loss Of Momentum, Outlining Prospects For 2025

Novartis: Explaining YE24 Loss Of Momentum, Outlining Prospects For 2025 #Novartis #Explaining #YE24 #Loss #Momentum #Outlining…